Steve O'Loughlin, Principal Financial Officer at Actinium Pharmaceuticals, Inc. (ATNM), bought 3,500 shares at $1.17 ($4K) on 2017-06-15, disclosed to the SEC on 2017-06-15.
Open-market purchase of $4k ATNM by Principal Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |